UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1534) 1534
amidohydrolases - antagonists & inhibitors (1444) 1444
life sciences & biomedicine (1432) 1432
animals (1316) 1316
amidohydrolases - metabolism (1051) 1051
humans (804) 804
male (689) 689
enzyme inhibitors - pharmacology (646) 646
rats (593) 593
pharmacology & pharmacy (574) 574
biological and medical sciences (561) 561
mice (469) 469
biochemistry & molecular biology (447) 447
endocannabinoids (444) 444
medical sciences (414) 414
enzymes (365) 365
amidohydrolases - genetics (354) 354
fatty acids (344) 344
enzyme inhibitors - chemistry (277) 277
structure-activity relationship (275) 275
pharmacology. drug treatments (274) 274
neurosciences (273) 273
arachidonic acids - metabolism (269) 269
neurosciences & neurology (258) 258
hydrolases (256) 256
anandamide (254) 254
lipids (254) 254
kinetics (253) 253
carbamates - pharmacology (249) 249
female (242) 242
fatty acid amide hydrolase (232) 232
rats, sprague-dawley (225) 225
dose-response relationship, drug (219) 219
chemistry (212) 212
benzamides - pharmacology (207) 207
amidohydrolases - chemistry (202) 202
fundamental and applied biological sciences. psychology (196) 196
endocannabinoids - metabolism (178) 178
hydrolysis (178) 178
piperidines - pharmacology (178) 178
physical sciences (176) 176
analysis (173) 173
arachidonic acids - pharmacology (170) 170
receptor, cannabinoid, cb1 - metabolism (169) 169
anti-bacterial agents - pharmacology (162) 162
polyunsaturated alkamides - metabolism (157) 157
chemistry, medicinal (156) 156
mice, inbred c57bl (153) 153
models, molecular (152) 152
disease models, animal (151) 151
polyunsaturated alkamides (151) 151
enzyme inhibitors - chemical synthesis (148) 148
substrate specificity (148) 148
hydrogen-ion concentration (139) 139
nervous system (139) 139
molecular structure (138) 138
research (137) 137
faah (136) 136
physiological aspects (135) 135
rats, wistar (135) 135
binding sites (132) 132
amino acid sequence (126) 126
arginine - analogs & derivatives (125) 125
pyrazoles - pharmacology (125) 125
mice, knockout (124) 124
cannabinoid receptor modulators - metabolism (122) 122
endocannabinoid (122) 122
molecular sequence data (119) 119
drug design (117) 117
monoacylglycerol lipases - antagonists & inhibitors (113) 113
microbiology (112) 112
cannabinoids (110) 110
receptor, cannabinoid, cb1 - antagonists & inhibitors (110) 110
amidohydrolases (108) 108
brain - metabolism (106) 106
cell biology (106) 106
fatty-acid amide hydrolase (103) 103
microbial sensitivity tests (103) 103
research article (103) 103
rodents (103) 103
nitric oxide (102) 102
psychological phenomena and processes (100) 100
brain - drug effects (99) 99
in vitro techniques (97) 97
psychiatry (93) 93
brain - enzymology (92) 92
cells, cultured (92) 92
hydrolase (92) 92
arginine - metabolism (90) 90
monoacylglycerol lipases - metabolism (90) 90
antibiotics. antiinfectious agents. antiparasitic agents (88) 88
chemistry, organic (87) 87
cannabinoid (85) 85
multidisciplinary sciences (85) 85
science & technology - other topics (85) 85
amidohydrolases - isolation & purification (84) 84
proteins (84) 84
escherichia coli - enzymology (83) 83
protein binding (83) 83
anti-bacterial agents - chemistry (82) 82
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2113) 2113
Russian (17) 17
Japanese (15) 15
German (13) 13
French (5) 5
Chinese (2) 2
Portuguese (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular and cellular endocrinology, ISSN 0303-7207, 01/2013, Volume 365, Issue 1, pp. 11 - 16
Asymmetric dimethylarginine | Nitric oxide synthase | Estrogen | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Endothelium, Vascular - cytology | Receptors, Estrogen - metabolism | Receptors, G-Protein-Coupled - metabolism | Humans | Endothelium, Vascular - drug effects | Estrogen Antagonists - pharmacology | Isoenzymes - chemistry | Receptors, G-Protein-Coupled - agonists | Estradiol - agonists | Arginine - analogs & derivatives | Nitric Oxide Synthase Type III - chemistry | Estrogen Receptor beta - metabolism | Estrogen Receptor alpha - agonists | Estrogen Receptor beta - agonists | Arginine - antagonists & inhibitors | Isoenzymes - metabolism | Estrogen Receptor alpha - metabolism | Nitric Oxide Synthase Type III - metabolism | Protein Stability | Estrogen Receptor beta - antagonists & inhibitors | Repressor Proteins - metabolism | Amidohydrolases - metabolism | Estradiol - metabolism | Receptors, Estrogen - agonists | Lipoproteins, LDL - adverse effects | Nitric Oxide - antagonists & inhibitors | Cells, Cultured | Receptors, Estrogen - antagonists & inhibitors | Amidohydrolases - antagonists & inhibitors | Estrogen Receptor alpha - antagonists & inhibitors | Amidohydrolases - chemistry | Blotting, Western | Nitric Oxide - agonists | Nitric Oxide Synthase Type III - antagonists & inhibitors | Protein-Arginine N-Methyltransferases - metabolism | Estradiol - chemistry | Lipoproteins, LDL - antagonists & inhibitors | Endothelium, Vascular - metabolism | Umbilical Arteries - cytology | Receptors, G-Protein-Coupled - antagonists & inhibitors | Arginine - adverse effects | Estrogens, Non-Steroidal - pharmacology | Nitric Oxide - metabolism | Arginine - metabolism | Isoenzymes - antagonists & inhibitors | Physiological aspects | Phenols | Estradiol | Nitric oxide | Endothelium | Index Medicus | Human | Proteins | Receptors | Inhibitors | Pathways | Estrogens | Exposure | Endothelial cells
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 0893-133X, 08/2013, Volume 38, Issue 9, pp. 1816 - 1824
Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Psychoses | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Schizophrenia | Biological and medical sciences | Medical sciences | Endocannabinoids - metabolism | Phencyclidine - pharmacology | Amygdala - drug effects | Male | Piperidines - antagonists & inhibitors | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB1 - physiology | Dose-Response Relationship, Drug | Arachidonic Acids - metabolism | Endocannabinoids - physiology | Prefrontal Cortex - drug effects | Receptor, Cannabinoid, CB1 - agonists | Piperidines - pharmacology | Schizophrenia - physiopathology | Social Behavior | Cannabinoid Receptor Antagonists - pharmacology | Benzamides - pharmacology | Cyclohexanols - pharmacology | Quinazolinones - pharmacology | Carbamates - pharmacology | Pyrazoles - pharmacology | Phencyclidine - antagonists & inhibitors | Amygdala - metabolism | Receptor, Cholecystokinin B - antagonists & inhibitors | Rats | Amidohydrolases - antagonists & inhibitors | Polyunsaturated Alkamides - metabolism | Animals | Prefrontal Cortex - metabolism | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Pyrazoles - antagonists & inhibitors | Index Medicus | endocannabinoid | animal models | negative symptoms | cholecystokinin | antipsychotics | cannabinoids | social interaction | Neuropharmacology | schizophrenia | PCP | Original
Journal Article
Nature neuroscience, ISSN 1097-6256, 09/2010, Volume 13, Issue 9, pp. 1113 - 1119
Journal Article
British journal of pharmacology, ISSN 0007-1188, 06/2013, Volume 169, Issue 4, pp. 794 - 807
Abn‐CBD | cannabidiol | endocannabinoid | CB1‐independent mechanism | PF750 | carbamate | off‐target | MAPK | dopamine | tyrosine hydroxylase promoter | off-target | Abn-CBD | CB1-independent mechanism | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Endocannabinoids - metabolism | Gene Expression Regulation, Enzymologic - drug effects | Tyrosine 3-Monooxygenase - metabolism | Cannabidiol - antagonists & inhibitors | Hippocampus - drug effects | Promoter Regions, Genetic - drug effects | Corpus Striatum - metabolism | Receptor, Cannabinoid, CB1 - agonists | Dopaminergic Neurons - metabolism | Cannabinoid Receptor Antagonists - pharmacology | Dopaminergic Neurons - drug effects | Hippocampus - enzymology | Animals, Outbred Strains | Antidepressive Agents - pharmacology | Benzamides - pharmacology | Corpus Striatum - enzymology | Carbamates - pharmacology | Amidohydrolases - metabolism | Nerve Tissue Proteins - antagonists & inhibitors | Peroxisome Proliferator-Activated Receptors - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Anti-Anxiety Agents - pharmacology | Tyrosine 3-Monooxygenase - antagonists & inhibitors | Amidohydrolases - antagonists & inhibitors | Nerve Tissue Proteins - genetics | Nerve Tissue Proteins - metabolism | Hippocampus - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Tyrosine 3-Monooxygenase - genetics | Dopaminergic Neurons - enzymology | Animals | Peroxisome Proliferator-Activated Receptors - metabolism | Cell Line, Tumor | Corpus Striatum - drug effects | Genes, Reporter - drug effects | Mice | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Cannabidiol - metabolism | Endocannabinoids - antagonists & inhibitors | Tyrosine | RNA | Physiological aspects | Phenols | Genetic research | Carbamates | Hydroxylases | Lipase | Fatty acids | Index Medicus | Cannabinoids 2012, Part Two | Themed Section
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 10/2011, Volume 339, Issue 1, pp. 173 - 185
Journal Article
Biochimica et biophysica acta. Molecular and cell biology of lipids, ISSN 1388-1981, 2006, Volume 1761, Issue 2, pp. 205 - 212
Journal Article
Nature communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, pp. 2384 - 2384
Journal Article
The Journal of pharmacology and experimental therapeutics, 12/2017, Volume 363, Issue 3, p. 314
Endocannabinoids - pharmacology | Male | Cannabinol - pharmacology | Drug Agonism | Enzyme Inhibitors - administration & dosage | Monoacylglycerol Lipases - metabolism | Glycerides - agonists | Cannabinoid Receptor Antagonists - pharmacology | Behavior, Animal - drug effects | Adamantane - administration & dosage | Adamantane - analogs & derivatives | Enzyme Inhibitors - adverse effects | Cannabinol - adverse effects | Adamantane - pharmacology | Cannabinol - analogs & derivatives | Nerve Tissue Proteins - agonists | Enzyme Inhibitors - pharmacology | Saimiri | Cannabinoid Receptor Antagonists - adverse effects | Glycerides - administration & dosage | Glycerides - pharmacology | Arachidonic Acids - antagonists & inhibitors | Endocannabinoids - administration & dosage | Ligands | Cannabinoid Receptor Antagonists - administration & dosage | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Endocannabinoids - antagonists & inhibitors | Drugs, Investigational - adverse effects | Drugs, Investigational - pharmacology | Injections, Intravenous | Endocannabinoids - agonists | Monoacylglycerol Lipases - antagonists & inhibitors | Arachidonic Acids - agonists | Dose-Response Relationship, Drug | Discrimination Learning - drug effects | Receptor, Cannabinoid, CB1 - agonists | Arachidonic Acids - administration & dosage | Adamantane - adverse effects | Amidohydrolases - metabolism | Nerve Tissue Proteins - antagonists & inhibitors | Cannabinol - administration & dosage | Amidohydrolases - antagonists & inhibitors | Injections, Intramuscular | Arachidonic Acids - pharmacology | Nerve Tissue Proteins - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Animals | Drug Antagonism | Drugs, Investigational - administration & dosage | Glycerides - antagonists & inhibitors
Journal Article